The provided UK guidelines do not specify the exact frequency for monitoring platelet counts in patients who have been diagnosed with essential thrombocythaemia NICE CKS,NICE CKS,NICE CKS.
However, the guidelines do outline criteria for referral to haematology for investigation and management of thrombocytosis, which may lead to a diagnosis of essential thrombocythaemia NICE CKS. For instance, referral to haematology is recommended for persistent and unexplained platelet counts over 450 × 109/L (for more than 3 months) or over 600 × 109/L on at least two occasions (4–6 weeks apart), or within the range 450–600 × 109/L with other haematological abnormalities NICE CKS.
For polycythaemia vera, another myeloproliferative neoplasm, annual follow-up is required, which can sometimes occur in primary care to detect transformation to myelofibrosis or acute myeloid leukaemia NICE CKS,NICE CKS. The management and follow-up for such conditions are typically directed by a haematologist and may depend on local protocols NICE CKS.